First thoughts….fantastic move. We always knew we had to partner with someone to progress and we have now done this.
this is I think only for testing if kidney disease so the market will remain open for archer to also explore other opportunities.
well done to Simon and the team for working hard on the road to commercialisation
Ann: AXE partners with Hylid Diagnostics for Biochip development, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.015(5.08%) |
Mkt cap ! $71.35M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.5¢ | $55.36K | 197.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30326 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 15979 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| AXE (ASX) Chart |